Mastocytosis, Systemic
Showing 26 - 50 of 8,222
Adaptation of Questionnaire "Regarding Patient's Quality of Life
Completed
- Cutaneous Mastocytosis
- Indolent Systemic Mastocytosis
- A structured interview with every patient
-
Toulouse, FranceUniversity Hospital Toulouse
Jul 15, 2019
Mast Cell Activation Disease, Mast Cell Activation Syndrome, Mast Cell Disease Trial in Poitiers (Ophthalmological examination)
Recruiting
- Mast Cell Activation Disease
- +3 more
- Ophthalmological examination
-
Poitiers, Nouvelle Aquitaine, FranceMasson Regnault
Apr 12, 2022
Systemic Mastocytosis Trial in France, Martinique (Mastocytosis diagnosis)
Completed
- Systemic Mastocytosis
- Mastocytosis diagnosis
-
Bordeaux, France
- +7 more
Jul 11, 2019
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial
Completed
- Chronic Myelogenous Leukemia
- +3 more
-
Duarte, California
- +100 more
Jun 8, 2021
Cause and Natural Course of Pediatric-Onset Mastocytosis
Completed
- Mastocytosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Are Mast Cells Involved in Autoinflammatory Diseases
Not yet recruiting
- Autoinflammatory Disease
- +5 more
-
Paris, FranceService de Médecine Interne
Mar 22, 2022
Indolent Systemic Mastocytosis Trial in Berlin (AK002)
Completed
- Indolent Systemic Mastocytosis
-
Berlin, GermanyCharité - Universitätsmedizin Berlin
Mar 12, 2019
Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis Trial in Stanford, Houston (Brentuximab vedotin)
Completed
- Aggressive Systemic Mastocytosis
- +2 more
- Brentuximab vedotin
-
Stanford, California
- +1 more
Jan 9, 2019
Mastocytosis Trial in Cambridge
Completed
- Mastocytosis
-
Cambridge, MassachusettsRegistry participation is worldwide and not limited to this faci
Feb 3, 2021
Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis Trial in Stanford (Ibrutinib)
Terminated
- Aggressive Systemic Mastocytosis
- +2 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Aug 24, 2018
Cutaneous Mastocytosis Trial in Toulouse (Pigment laser)
Recruiting
- Cutaneous Mastocytosis
- Pigment laser
-
Toulouse, FranceLarrey Hospital - Toulouse University Hospital
Sep 23, 2020
Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell, Hematological Non-mast Cell Lineage Disease (AHNMD) Trial in
Completed
- Systemic Mastocytosis, Aggressive (ASM)
- +2 more
-
Stanford, California
- +2 more
Sep 19, 2018
Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)
Recruiting
- Core Binding Factor Acute Myeloid Leukemia
- KIT Mutation-Related Tumors
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital of Soochow University
Apr 7, 2023
Mastocytosis Trial (masitinib (AB1010))
Completed
- Mastocytosis
- masitinib (AB1010)
- (no location specified)
Dec 8, 2018
Mast Cell Activation Syndrome Trial in Weldon Spring, Toulouse (Masitinib 4.5 mg/kg/day, Placebo, Best supportive care)
Recruiting
- Mast Cell Activation Syndrome
- Masitinib 4.5 mg/kg/day
- +3 more
-
Weldon Spring, Missouri
- +1 more
Jul 18, 2022
Serum Basal Tryptase Levels in Healthy Children
Completed
- Basal Tryptasemia
- Tryptase dosage
-
Paris, FranceHôpital Necker-Enfants Malades
Dec 8, 2022
Patient With Facial Erythema Trial in Assiut (Tranexamic Acid 500 MG)
Completed
- Patient With Facial Erythema
- Tranexamic Acid 500 MG
-
Assiut, EgyptAzhar University
Jun 9, 2023
Relevance of Self-assessment of Skills for Self-administration
Not yet recruiting
- Severe Anaphylactic Reaction, Self-administration, Adrenaline, Self-assessment
- (no location specified)
May 30, 2022
Study of Factors Regulating Mast Cell Proliferation
Recruiting
- Mastocytosis
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the
Not yet recruiting
- Inherited Bone Marrow Failure Syndrome
- Familial Platelet Disorder With Predisposition to Myeloid Malignancies
- imatinib
- TruSight Oncology
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 20, 2023
Cutaneous Mastocytoses Trial in Rochester (Topical preparation of sodium cromolyn 5%, diphenhydramine 1% and trolamine
Recruiting
- Cutaneous Mastocytoses
- Topical preparation of sodium cromolyn 5%, diphenhydramine 1% and trolamine salicylate 10% in emollient cream base.
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 11, 2022
Schizophrenia, Schizo Affective Disorder Trial in Pittsburgh (Cromoglycate, Placebo)
Recruiting
- Schizophrenia
- Schizo Affective Disorder
- Cromoglycate
- Placebo
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Jan 4, 2023
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Dec 7, 2021
Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Standard systemic therapy + radiotherapy
- Standard systemic therapy
-
Gothenburg, Sweden
- +5 more
Nov 17, 2023